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Figure 1. PI3K Is Required for Glycine-Induced LTP of mEPSCs in Cultured Hippocampal Neurons
Cultured hippocampal neurons were either incubated in extracellular solution (ECS; control) or ECS supplemented with wortmannin (100 nM;
Wortmannin) 10 min before and throughout the recording period. (A) Examples of continuous recordings from individual neurons immediately
before (Basal) and 20 min after glycine application (Glycine, 200 M). (B) Examples of individual mEPSCs averaged from 120 events before
(Basal) and 20 min after glycine (Glycine). (C) Cumulative probability plots for mEPSC amplitudes and interevent intervals obtained before
(Basal) and 20 min after glycine (Glycine, 200 M; 3 min). mEPSC amplitudes are normalized to the values from the initial 5 min and plotted
over time in (D). In the absence of the PI3K inhibitor wortmannin (Control), brief application of glycine in the bath solution reliably induces
LTP of mEPSCAMPA, as reported previously (Lu et al., 2001). Treatment of neurons with wortmannin (Wortmannin; 100 nM) has no effect on
basal mEPSCs over the time course of recordings, but in the presence of wortmannin, glycine was no longer capable of producing LTP. (E)
Amplitude histogram summarizes data from groups of individual neurons treated with glycine (200 M; 5 min) in the absence or presence of
PI3K inhibitors wortmannin (100 nM) or LY294002 (10 M). Responses obtained 20 min after glycine treatment were normalized to the values
from the initial 5 min of recording. Glycine produced LTP which is prevented by inhibition of PI3K with wortmannin (1.23  0.05, n  6 for
glycine versus 0.96  0.03, n  4 for Gly  Wort) or with LY294002 (1.41  0.16, n  10 versus 0.96  0.06, n  6). *p  0.05.
recently developed LTP (Liao et al., 2001; Lu et al., 2001) it requires Ca2 influx through activated postsynaptic
NMDARs and results from an increase in the plasmaand LTD (Carroll et al., 1999) models in cultured hippo-
campal neurons. Miniature excitatory postsynaptic cur- membrane insertion of postsynaptic AMPARs (Lu et al.,
2001). The increased mEPSC frequency is likely due torents (mEPSCs) in cultured hippocampal neurons were
recorded under whole-cell configuration. These mEPSCs the addition of events (following glycine-induced recep-
tor insertion) that were previously below the detectionare comprised of two pharmacologically distinct com-
ponents: a prominent fast component mediated by threshold. The glycine-induced LTP of mEPSCs is in
striking contrast to the LTD of mEPSCs produced byAMPARs (mEPSCAMPA) and a much smaller and slower
component mediated by NMDARs (mEPSCNMDA) (Lu et stimulation of NMDARs with bath application of NMDA
(10 M; 3 min) (Beattie et al., 2000; Lu et al., 2001; Figureal., 2001). Similar to the electrically evoked EPSCs in
CA1 neurons in hippocampal slices (Bear and Malenka, 2). This LTD of mEPSCs resembles the CA1 homosynap-
tic LTD characterized in hippocampal slices (Bear and1994; Bliss and Collingridge, 1993; Zorumski and Thio,
1992), the mEPSCs can exhibit either LTP (Lu et al., Malenka, 1994): it requires NMDA channel-gated Ca2
influx, activation of calcineurin, and subsequent stimula-2001) or LTD (Carroll et al., 1999; Lu et al., 2001), de-
pending upon the ways by which NMDARs are pharma- tion of clathrin-dependent endocytosis of AMPARs
(Beattie et al., 2000).cologically activated (Lu et al., 2001). As shown in Figure
1, application of the NMDAR coagonist glycine (200 M; What are the intracellular signaling pathways that pro-
duce either net AMPAR insertion or internalization,3 min) produced LTP of mEPSCs, as shown by the per-
sistent increase in both amplitude and frequency, spe- thereby dictating the expression of these two opposing
forms of NMDAR-dependent synaptic plasticity? Amongcifically the mEPSCAMPA component (Lu et al., 2001) (see
also Figure 3E; the amplitude and frequency of mEPSCs many potential intracellular factors involved in mediating
plasma membrane protein trafficking, we investigated20 min after glycine being 1.23  0.06 and 1.34  0.07
of the controls, respectively; n  6; p  0.01). This the potential role of PI3K. Activation of this lipid kinase
has recently been implicated in both plasma membraneparticular form of potentiation of mEPSCs shares sev-
eral similarities with the well-characterized hippocampal protein insertion (De Camilli et al., 1996; Passafaro et al.,
2001; Pessin et al., 1999) and internalization processesCA1 homosynaptic LTP observed in slice preparations:
Role of PI3K in AMPA Receptor Insertion during LTP
613
Figure 2. PI3K Is Not Involved in NMDA-Induced LTD of mEPSCs in Cultured Hippocampal Neurons
(A) Examples of continuous recordings immediately before (Basal) and 20 min after NMDA application (NMDA, 20 M plus 10 M glycine; 5
min) from individual neurons incubated with ECS (Control) or ECS supplemented with 100 nM wortmannin (Wortmannin) 10 min prior to NMDA
application and throughout the recording period.
(B) Amplitude histogram summarizes data from groups of individual neurons treated with NMDA (20 M plus 10 M glycine) in the absence
(NMDA; n  6) or the presence of 100 nM wortmannin (NMDA  Wort; n  4). Responses obtained 20 min after glycine treatment were
normalized to the values from the initial 5 min of recording. Inhibition of PI3K has little effect on NMDA-induced LTD (0.78  0.08 for NMDA
versus 0.81  0.08 for NMDA  Wort).
(Rapoport et al., 1997; Shpetner et al., 1996). To deter- ized amplitude and frequency following 30 min of re-
cording were 1.25  0.05 and 1.35  0.07 with activemine whether PI3K plays any role in mediating either
LTP or LTD of mEPSCs, wortmannin (100 nM), a PI3K PI3K (n  6) and 1.01  0.03 and 0.99  0.04 for cells
recorded with heat-inactivated PI3K (n  4; Figure 3D),inhibitor (Wymann et al., 1996), was bath applied to
cultured hippocampal neurons 10 min prior to bath ap- respectively. Moreover, once the potentiation of
mEPSCs by PI3K was established, glycine was no longerplication of either glycine or NMDA and was present
throughout the recording period. Wortmannin produced capable of inducing LTP of mEPSCs (Figure 3E). Thus,
normalized mEPSCAMPA amplitude and frequency 30 minlittle effect on the basal mEPSCs (amplitude and fre-
quency before and 20 min after wortmannin being after glycine application were 0.99  0.05 and 1.02 
0.03 for cells (n 3) perfused with active PI3K compared24.48  1.73 pA versus 22.1  1.02 pA and 2.32  0.37/
s versus 2.09  0.25/s; n  7; p  0.05). However, as with 1.230.06 and 1.340.07 for cells (n 6) recorded
with standard pipette solution (Figure 3E), respectively.shown in Figure 1, wortmannin abolished the ability of
glycine to induce LTP of mEPSCs. The amplitude of Taken together, these results strongly suggest that PI3K
activation is both necessary and sufficient for the gly-mEPSCs after glycine application was 1.23  0.05 (n 
6) and 0.96  0.03 (n  6) -fold of the controls in the cine-dependent LTP of mEPSCs by synaptic NMDARs.
We previously demonstrated that glycine-inducedabsence and the presence of wortmannin, respectively
(Figures 1A–1E). Moreover, a similar blockade was ob- LTP is largely mediated by a rapid increase in the number
of postsynaptic AMPARs as a result of facilitatedtained when LY294002 (10 M), another, more specific,
inhibitor of PI3K (Kuruvilla et al., 2000), was employed AMPAR insertion (Lu et al., 2001). The necessity and
sufficiency of PI3K in glycine-induced LTP is consistent(Figure 1E). In dramatic contrast, as shown in Figure 2,
we found that PI3K inhibition had little effect on the with a requirement for its activity in the glycine-induced
increase in plasma membrane insertion of AMPARs. WeNMDA-induced LTD of mEPSCs: the amplitudes of
mEPSCs after NMDA application were 0.78  0.08 (n  next investigated this possibility by measuring the cell
surface expression of AMPARs using a quantitative cell5) and 0.80  0.03 (n  4), respectively. Thus, PI3K is
specifically required for glycine-induced LTP but not surface ELISA assay (Lu et al., 2001; Man et al., 2000b).
We found that application of glycine produced an in-NMDA-induced LTD.
We next determined whether exogenous PI3K appli- crease in the cell surface expression of AMPARs, and
this increase was prevented by pretreatment withcation was sufficient to produce a lasting potentiation
of mEPSCs (Figure 3) by using an active or a heat- LY294002 and significantly inhibited by pretreatment
with wortmannin (Figure 4A). Since cell surface expres-inactivated recombinant PI3K complex of p85/p110
(Figure 3C) applied intracellularly through the recording sion can be modified by either insertion or endocytosis,
we examined both of these aspects of AMPAR traffick-pipette. As shown in Figures 3A, 3B, and 3D, within a few
minutes of the start of whole-cell recording, intracellular ing, in the presence and absence of PI3K inhibitors, in
control and glycine-treated hippocampal cultures. Spe-perfusion of active but not heat-inactivated PI3K re-
sulted in an increase in both the amplitude and fre- cific detection of newly inserted AMPARs was per-
formed using our recently developed AMPAR insertionquency of mEPSCs. The potentiation of mEPSCs typi-
cally peaked within 10 min, and was maintained assay (Lu et al., 2001). In this assay, preexisting cell
surface AMPARs were first blocked by incubation ofthereafter for the entire recording period. The normal-
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Figure 3. Active PI3K Potentiates mEPSCs and Occludes Glycine-Induced LTP
(A) Continuous traces of mEPSCs taken at the times indicated from a hippocampal neuron recorded with intracellular solution containing
active PI3K (1 g/ml).
(B) Averaged mEPSCs (n  100 events) taken at 2 and 15 min after the start of whole-cell recordings from two individual neurons recorded,
respectively, with active and heat-inactivated, purified PI3K-containing intracellular solutions.
(C) Active PI3K was purified from Sf9 cells infected with recombinant p85- and p110-expressing baculovirus. As shown on the Coommassie
blue-stained SDS gel (left), the purified complex yielded two bands as expected for the recombinant p85 and p110 subunits of PI3K.
Catalytically inactive PI3K was obtained by boiling the purified p85/p110 complex for 10 min. Lipid kinase activity of active and heat-
inactivated PI3K complexes was assayed using exogenous phosphatidylinositol (PtdIns) and 32P-	-ATP as substrates (see Experimental
Procedures). As shown in the autoradiogram on the right, the active but not the heat-inactivated (HI PI3K) PI3K complex phosphorylated
PtdIns substrates and generated PtdIns-3P.
(D) Plots summarize data from cells recorded with active (Active PI3K; amplitude of 1.25  0.06 and frequency of 1.35  0.07; n  6) or heat-
inactivated PI3K (HI PI3K; 1.01  0.03 and 0.99  0.04; n  5) in the patch pipettes. The amplitudes and frequencies of mEPSCs at 30 min
were normalized to the values from the initial 2 min. Both the amplitudes and frequencies of mEPSCs increased following intracellular
application of active but not heat-inactivated recombinant PI3K.
(E) Graphs show the occlusion of glycine-induced LTP of mEPSCs by intracellular pretreatment with PI3K. For cells recorded with active PI3K
in the patch pipette (Gly after PI3K), the amplitude and frequency measured 20 min after the start of whole-cell recording, at which point the
potentiation of mEPSCs by PI3K had stabilized at its peak value, were normalized to the values 30 min after the glycine application. For the
controls (Glycine), glycine was applied at the same time point as the Gly after PI3K group. In the absence of active PI3K in the recording
pipette, both mEPSC amplitude and frequency were enhanced (Glycine; 200M, 1.23 0.06 and 1.34 0.07; n 6). However, this enhancement
was absent in cells recorded with active PI3K in the patch pipette (Gly after PI3K; 0.99  0.05 and 1.02  0.03; n  4), which increased both
mEPSC amplitude and frequency to a degree similar to glycine application.
live neurons with an antibody against an amino-terminal there were newly inserted GluR2-stained clusters on
the surface of soma and dendritic trees, representing aextracellular epitope of the GluR2 subunit and a cold
(non-fluorescence-conjugated) secondary antibody at rapid, constitutive insertion of AMPARs into the plasma
membrane (Lu et al., 2001). As previously reported, most4
C. Neurons were then transferred to 37
C to allow the
resumption of AMPAR insertion for various periods of of these GluR2 clusters were colocalized with the synap-
tic marker synaptophysin, suggesting that some if nottime in the presence or absence of glycine and/or PI3K
inhibitors. Newly inserted AMPARs were then labeled all of the receptors were inserted directly at synaptic
sites (see Figure 7A in Lu et al., 2001). Treatment withwith the same primary antibody followed by a Cy3-con-
jugated secondary antibody for fluorescent confocal im- glycine (200 M; 3 min) produced a dramatic increase
in the number of newly inserted GluR2 clusters (Figureaging (Figure 4B) or an HRP-conjugated secondary anti-
body for cell-ELISA quantification (Figure 4C) under 4B). Quantification of the AMPAR insertion using a non-
biased cell-ELISA assay (Figure 4C) demonstrated thatnonpermeant conditions following light fixation. Intra-
cellular AMPARs were subsequently stained with the glycine treatment resulted in a more than 2-fold increase
in newly inserted AMPARs (2.2  0.08; n  49; p  0.05)same primary antibody and FITC- or HRP-conjugated
secondary antibody under cell-permeant conditions. and that this increase was prevented when LY294002
(10 M) was present during and after glycine treatmentThe specificity of this method has been characterized
previously (see Figure 7B in Lu et al., 2001), and the (0.98  0.05; n  49; p  0.05). Interestingly, the inhibi-
tion by LY294002 of the glycine-induced increase inlack of immunofluorescent staining at time 0 (without
switching the cells to room temperature) further con- AMPAR insertion was reversible. Thus, 30 min after
washing out LY294002, the level of newly insertedfirmed the effective blockade of the preexisting cell sur-
face AMPARs by the cold antibody (Figure 4E). As shown AMPARs on the membrane surface returned to 1.8 
0.07 -fold of the control level (n  49; p  0.05; Figurein Figure 4B, 30 min after switching the cells to 37
C,
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Figure 4. Activation of PI3K Increases Cell Surface Expression of AMPARs by Facilitating Receptor Insertion
(A) Measuring steady-state cell surface AMPARs using colorimetric cell-ELISA assays demonstrates that glycine application results in a rapid
increase in the cell surface expression of AMPARs and that this increase is fully blocked by LY294002 (10 M, n  6) and partially inhibited
by wortmannin (100 nM; n  6). *p  0.05, comparing with its own control (values before glycine treatment) and #p  0.05, comparing with
treatment with glycine alone. (B and C) PI3K is involved in facilitation of AMPAR insertion. After blocking existing cell surface AMPARs with
primary antibody recognizing the N-terminal extracellular domain of GluR2 and cold (non-fluorescence-conjugated) secondary antibody,
neurons were incubated at 37
C in the absence (Control) or presence of one of the indicated drug treatments for 30 min. The newly inserted
cell surface AMPARs were then visualized using confocal microscopy or quantified using a cell-ELISA assay. Example images of newly inserted
cell surface (red; nonpermeabilized) and intracellular (green; permeabilized) AMPARs under control (Control) or following glycine treatment
(Glycine; 100 M; 5 min) are shown in (B). Double staining of cells with GluR2 (red; nonpermeabilized) and synaptophysin (green; permeabilized)
immediately after preblocking shows that the preblock, while having no effect on synaptophysin staining, essentially eliminated GluR2 labeling
(GluR2), confirming the specific and effective blockade of preexisting cell surface AMPA receptors (E). A histogram of the quantification of
the glycine-induced increase in AMPAR insertion using the cell-ELISA assay is shown in (C). Glycine facilitated AMPAR insertion (Glycine),
and this facilitation was prevented by 10 M LY294002 (Gly  LY). Moreover, 30 min after LY294002 was washed off the cells (LY Wash),
there was a significant recovery of the glycine-induced increase in AMPAR insertion (n  49). (D) Glycine does not inhibit the AMPAR
endocytosis process. The cell surface AMPARs were prelabeled with an antibody raised against an N-terminal extracellular epitope of GluR2
in live neurons at 4
C and allowed to endocytose for varying lengths of time at 37
C. AMPARs remaining on the cell surface and those
internalized into the interior of the cells were then quantified using the cell-ELISA assay with HRP-conjugated secondary antibodies under
nonpermeant and permeant conditions. The level of AMPAR endocytosis was determined by the specific loss of the prelabeled surface
receptors. Glycine treatment did not inhibit but slightly increased AMPAR endocytosis (Glycine; 1.04  0.01 of the control level, n  49),
which was not observed in the presence of LY294002 (Gly  LY; 0.98  0.01).
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Figure 5. PI3K Is Associated with AMPARs
(A) Colocalization of PI3K with AMPARs in cultured hippocampal neurons. Confocal optical sections of the subcellular distribution of PI3K
and AMPARs in the dendrites of a cultured neuron. The p85 subunit of PI3K ([Aa] p85; green) and AMPAR GluR2 subunits ([Ab] GluR2; red)
were sequentially stained under permeant conditions. The neurons were then subsequently stained with an antibody against synaptophysin
to visualize all synapses ([Ac] Synaptophysin; blue). The superimposed image is shown in (Ad) (merged). The split color channels of the inset
indicated in (Ad) were enlarged in panels (Aa)–(Ad) and show a high degree of colocalization (see example indicated by the arrows) between
PI3K and AMPARs in the dendrites and synapses in punctate clusters near regions stained for synaptophysin, suggesting that the kinase can
be compartmentalized to glutamatergic synaptic regions.
(B) PI3K forms a complex with AMPARs in mature brain tissue. (Upper panels) Protein complexes, immunoprecipitated with an anti-p85
antibody from rat hippocampal slice extracts under nondenaturing conditions, were sequentially probed with anti-GluR2 (GluR2) or anti-
NMDAR1 (NMDAR1) antibodies. Anti-p85 antibody but not control IgG was able to immunoprecipitate GluR2 but not NMDAR1. (Lower panels)
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4C). These results strongly suggest that activation of colocalized with AMPAR GluR2 subunits at synapses
as shown in the overlay panel (also see inset in FigurePI3K is required for glycine-induced facilitation of
AMPAR insertion, possibly by being involved at a late 5Ad of the overlay panel). These staining results sug-
gest that PI3K and AMPARs can colocalize in discretestep of the receptor insertion process. We next exam-
ined the effect of PI3K inhibition on AMPAR endocytosis punctate regions and that many of these are localized
near synapses.using a receptor endocytosis assay (antibody-feeding
assay) described previously (Lin et al., 2000; Man et al., One potential mechanism by which PI3K could be
compartmentalized at glutamatergic synapses is2000b). Live neurons were prelabeled with an antibody
against extracellular GluR2 at 4
C. The cells were through association with synaptically localized proteins,
such as glutamate receptors themselves and/or theirswitched to 37
C to allow the resumption of receptor
endocytosis, and 30 min later, the prelabeled receptors clustering proteins. We therefore immunoprecipitated
PI3K from rat hippocampal lysates using an antibodyremaining on the cell surface and those endocytosed
into intracellular compartments were detected using a against the p85 subunit under nondenaturing conditions
and then sequentially probed the immunoprecipitatedcell-ELISA assay under nonpermeant and permeant
conditions, respectively (Man et al., 2000b). As pre- protein complex using antibodies against either GluR2
subunits or the NMDAR NR1 subunit in order to investi-dicted, glycine treatment did not inhibit AMPAR endocy-
tosis but instead resulted in a small but statistically sig- gate whether PI3K is associated with either NMDARs
or AMPARs. As shown in Figure 5B, AMPA (both GluR1nificant facilitation of endocytosis. The facilitation of
endocytosis is most likely due to a compensatory re- and GluR2 subunits) but not NMDA receptors were spe-
cifically coimmunoprecipitated with PI3K under nondena-sponse secondary to glycine stimulation of the AMPAR
insertion process (Liang and Huganir, 2001; Man et al., turing conditions. The immunoprecipitation of AMPAR
subunits was not seen with control IgG, nor when the2000b). Consistent with this conjecture, as with the gly-
cine-induced increase in AMPAR insertion (Figure 4C), samples were boiled for 5 min (to dissociate protein
complexes) prior to the immunoprecipitation. Thus, PI3Kthis facilitation of endocytosis was prevented by
LY294002 (Figure 4D). Thus, taken together, our results appears to complex with AMPARs in hippocampal neu-
rons. The failure to coimmunoprecipitate NMDARs withindicate that glycine stimulation increases the number
of cell surface AMPARs in a PI3K-dependent manner PI3K is surprising, as a previous study reported an asso-
ciation of PI3K with these receptors via a direct interac-and that the increase is primarily the result of facilitated
receptor insertion and not due to inhibited receptor en- tion between the tyrosine phosphorylated NR2B subunit
and p85 (Hisatsune et al., 1999). One potential explana-docytosis.
PI3K has been shown to exert diverse biological ac- tion is that the level of endogenous tyrosine phosphory-
lation of NMDARs under our experimental conditionstions even within the same cell; however, stimulus-
dependent specificity of its actions is possible, and in was too low to support such a tyrosine phosphorylation-
dependent complex formation. To further determinemost cases, this specificity is critically dependent upon
its compartmentalization with downstream effectors whether the PI3K complexed with AMPARs was func-
tional, we coimmunoprecipitated PI3K using an anti-(Heller-Harrison et al., 1996; Yang et al., 1996). We there-
fore reasoned that the subcellular localization of PI3K GluR2 antibody, and measured the ability of the AMPAR-
associated PI3K to form PtdIns 3-P from PtdIns andactivation within the activated synapse might account
for the specific involvement of this lipid kinase in the 32P-	-ATP (Figure 5C). This immunocomplex/lipid kinase
assay revealed that GluR2 antibodies were able to pre-LTP but not the LTD of mEPSCs. To test our hypothesis,
we first determined whether PI3K was present in the cipitate PI3K activity, whereas control IgG was not. Pre-
incubation with wortmannin completely blocked theglutamatergic synapses of cultured hippocampal neu-
rons using immunofluorescent confocal microscopy. AMPAR-associated PI3K activity. These results not only
confirm that PI3K is associated with AMPARs in hippo-PI3K was first labeled in cultured neurons with an anti-
body against the p85 subunit, and the same neurons campal neurons in situ, but also demonstrate that the
receptor-kinase complex is functionally active.were subsequently stained for postsynaptic AMPAR
GluR2 subunits in order to identify glutamatergic syn- The receptor-kinase complex could form directly, by
interaction between the AMPAR and PI3K, or indirectly,apses. As a final step, all synapses on the hippocampal
neurons were detected via staining for synapse-specific with the aid of a bridging protein(s). To determine
whether or not the PI3K-AMPAR association is mediatedsynaptophysin. As shown in Figure 5A, PI3K was local-
ized throughout the neurons, including in dendrites. No- by a direct interaction, we performed an in vitro recombi-
nant protein binding assay. Native AMPARs are likelytably, within the dendrites PI3K was not uniformly dis-
tributed but was found in numerous small clusters and heterooligomeric complexes assembled from GluR1-4
subunits, and the most common subunit combinationsin what appeared to be spines (panel inset in Figure
5Aa). The majority of these dendritic PI3K punctae were of native AMPARs in hippocampal CA1 neurons are
Sequential immunoblotting for GluR2 and GluR1 shows that both subunits are present in p85 immunoprecipitated complexes and that boiling
the samples for 5 min (to denature protein complexes) prior to the immunoprecipitation eliminated the ability of the anti-p85 antibody to
coimmunoprecipitate either GluR2 or GluR1.
(C) PI3K in the AMPAR complex is functional. PI3K assays were performed on protein complexes immunoprecipitated with anti-GluR2 antibody
under nondenaturing conditions. Anti-GluR2 antibody but not the control IgG was able to immunoprecipitate lipid kinase activity (see arrowhead
for kinase reaction product), which was completely abolished by the addition of the PI3K inhibitor wortmannin in the kinase assay buffer
(Wort; 100 nM; 10 min).
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Figure 6. Direct Interaction between PI3K and AMPAR
(A) Sequence alignments of GST constructs containing the carboxyl tails of GluR1 and GluR2. The highly conserved region among all GluR
subunits is underlined.
(B) Both GluR1 and GluR2 interact with PI3K (p85/p110) complex in vitro. The purified active recombinant PI3K complex (p85/p110; see Figure
3C) was incubated with GST or GST fusion proteins containing either GluR1 (GST-GluR1CT) or GluR2 (GST-GluR2CT) carboxyl tail, and the
affinity precipitates, along with purified PI3K (PI3K) as a positive control, were then subjected to a PI3K activity assay. Both GST-GluR1CT and
GST-GluR2CT but not GST alone were able to bind and, hence, precipitate the PI3K complex.
(C) The p85 subunit of PI3K binds to GST-GluR1CT and GST-GluR2CT in vitro. The p85 subunit of PI3K was in vitro translated and radioactively
labeled with [35S]methionine. The autoradiogram on the left shows that the reaction produced a single protein band with a molecular weight
corresponding to the p85 subunit. (Right) The in vitro translated p85 was then incubated with GST, GST-GluR1CT, or GST-GluR2CT, and the
precipitates were subjected to SDS-PAGE. Autoradiography shows that both GST-GluR1CT and GST-GluR2CT but not GST alone precipitate
the p85 subunit (top). A Coommassie blue-stained gel (bottom) indicates that a similar amount of GST fusion protein was used in each of the
precipitation experiments.
(D) Autoradiogram shows that GST fusion protein containing the first 21 amino acids of the GluR2 CT (GST-GluR2833–853, the conserved region)
but not GST fusion protein containing the last 30 amino acids of the GluR2 CT (GST-GluR2854–883) nor GST alone was capable of precipitating
the p85 subunit.
(E) Direct interaction between p85 and GluRs is responsible for the complex formation between PI3K and AMPARs in mature neurons in situ.
Hippocampal lysates were immunoprecipitated with anti-GluR2 antibody in the absence (Control) or presence of one of the GST fusion proteins
(50 g) under nondenaturing conditions, and the immunoprecipitates were then separated on SDS-PAGE and sequentially probed for p85
and GluR2. GST-GluR2833–853 but not GST-GluR2854–883 nor GST alone inhibited the ability of anti-GluR2 antibody to coimmunoprecipitate p85.
Result represents one of two replicates.
GluR1/GluR2 and GluR2/GluR3 (Wenthold et al., 1996). lated, [35S]methionine-labeled p85 subunits using an af-
finity precipitation assay (Figure 6C). Since there is aIn addition, several intracellular proteins associate with
AMPARs via their binding to the cytoplasmic carboxyl short amino acid stretch at the N-terminal end of the
CT (membrane proximal region) that is highly conservedtails (CTs) of GluRs (Kim and Huganir, 1999; Sheng and
Sala, 2001). We therefore incubated purified recombi- among all GluR subunits, we suspected that it was this
conserved region that was involved in the interactionnant p85/p110 PI3K with GST fusion proteins con-
taining the CT of GluR1 (GST-GluR1CT) or GluR2 (GST- between PI3K and GluRs. We therefore created two
additional GST-GluR2CT fusion proteins, GST-GluR2833–853GluR2CT) subunits and assayed whether these fusion
proteins could specifically affinity precipitate the PI3K and GST-GluR2854–883 (Figure 6A). The former includes
the membrane proximal conserved region, the lattercomplex as measured by PI3K activity in the precipi-
tates. As shown in Figure 6, both GST-GluR1CT and GST- does not. Consistent with our predictions, GST-GluR2833–
853 but not GST-GluR2854–883 was able to interact with p85GluR2CT but not GST alone were able to precipitate ac-
tive PI3K, supporting the interpretation of direct binding (Figure 6D). To further determine whether the identified
direct binding is the primary mechanism responsible forbetween the PI3K complex and these GluR CTs. The
p85 regulatory subunit of PI3K contains multiple pro- complex formation between native AMPAR and PI3K
detected by coimmunoprecipitation shown in Figure 5,tein-protein interaction motifs (Vanhaesebroeck et al.,
1997). Therefore, we hypothesized that this subunit di- we performed immunoprecipitation of hippocampal ly-
sate with anti-GluR2 antibody in the presence of GSTrectly binds to regions of the GluR CT. Consistent with
this hypothesis, we found that both GST-GluR1CT and alone, GST-GluR2833–853, or GST-GluR2854–883. As shown in
the blots in Figure 6E, the GST-GluR2833–853 but neitherGST-GluR2CT could specifically precipitate in vitro-trans-
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GST alone nor GST-GluR2854–883 drastically reduced the AMPAR insertion (Figure 4). Collectively, these results
amount of p85 present in the immunoprecipitates. The strongly suggest that AMPAR-PI3K interaction leads to
reduction in p85 was not associated with a notable alter- the compartmentalization of PI3K in the postsynaptic
ation of GluR2 in the immunoprecipitates. Thus, the domain of the glutamatergic synapse, thereby enabling
GST-GluR2833–853 that contains the binding motif for p85 the stimulation of the lipid kinase by synaptic NMDAR
was able to compete with native AMPARs for the binding activation. These results also correspond well with our
of endogenous p85, thereby inhibiting complex forma- electrophysiological results demonstrating the specific
tion between PI3K and AMPARs. The GluR2833–853 region requirement for PI3K in glycine-induced LTP (Figure 1),
appears to be both necessary and sufficient for mediat- but not in NMDA-induced LTD, of mEPSCs (Figure 2).
ing GluR-p85 binding and, therefore, AMPAR and PI3K
association in situ. Discussion
The association of PI3K and AMPARs puts this kinase
in a strategic position to mediate the facilitated insertion Our data presented here demonstrate that PI3K is asso-
of these receptors during glycine-induced LTP. It has ciated with AMPARs and is thereby compartmentalized
recently been demonstrated that calmodulin can bind within the excitatory synapses of hippocampal neurons.
to and activate PI3K in a Ca2-dependent manner (Joyal Activation of synaptic NMDARs with glycine specifically
et al., 1997). As AMPARs and NMDARs coexist in post- stimulates the AMPAR-associated PI3K. In addition, we
synaptic membranes of glutamatergic synapses, we demonstrate that activation of PI3K plays an indispens-
reasoned that the AMPAR-PI3K interaction might com- able role in the glycine-induced facilitation of the inser-
partmentalize PI3K near NMDAR channels. Since activa- tion of postsynaptic AMPARs and, hence, LTP of
tion of synaptic NMDARs can lead to a localized and mEPSCs. Moreover, we found that the prevention of
transient rise in intracellular Ca2concentrations ([Ca2]i) facilitated AMPAR insertion by inhibiting PI3K activity
within the activated postsynaptic dendritic spines, this could be reversed upon removal of the PI3K inhibitor.
molecular arrangement would allow the selective stimu- These results are in good agreement with recently re-
lation of the AMPAR-associated PI3K complex only at ported involvement of PI3K in mediating the expression
those activated synapses where an NMDAR-dependent but not the induction and maintenance of hippocampal
influx of Ca2 was induced. We examined this possibility CA1 LTP in slice preparations (Sanna et al., 2002). To-
by measuring the PI3K activity of AMPAR-kinase com- gether, our results strongly suggest that PI3K is required
plexes immunoprecipitated from hippocampal slices for facilitated AMPAR insertion, making it a critical mole-
pretreated with or without different glutamate receptor cule that is directly involved in mediating the later step
agonists or glycine. As a control, and in parallel, the of LTP.
activity of the entire cellular pool of PI3K from these Through our in vitro recombinant protein binding
slices was also measured via immunoprecipitation with assays, we identified a direct interaction between the
an anti-p85 antibody. Consistent with our hypothesis, membrane proximal region of the CTs of GluR subunits
bath application of glycine (200 M for 5 min) resulted and the p85 subunit of PI3K. Since the short peptide
in a more than 2-fold increase in the PI3K activity associ-
containing this binding region dramatically inhibits the
ated with the anti-GluR2, but not the anti-p85, immuno-
coimmunoprecipitation of PI3K protein (Figure 6E) and
complex (Figures 7A and 7B), and this increase was the
activity (Figure 7D) with AMPARs, it is likely that the
result of synaptic activation of NMDARs as the glycine
identified direct binding is the primary determinant thateffect was blocked by APV (50 M). Surprisingly, bath
mediates complex formation between PI3K and AMPARsapplication of neither NMDA (50 M), which activates
in neurons. It is interesting that this required region isboth synaptic and extrasynaptic NMDARs and produces
largely conserved among all GluR subunits identifiedLTD of mEPSCs (Lu et al., 2001), nor AMPA (50 M)
thus far. This implies that the association betweennotably altered either anti-GluR2 or anti-p85 immuno-
AMPARs and PI3K is not a subunit-specific phenome-precipitated PI3K activity (Figures 7A and 7B). This gly-
non but is common to all native AMPARs, underscoringcine-induced increase in AMPAR-associated PI3K activ-
the physiological importance of the association. It isity appears to be the result of the activation of the kinase
interesting to note that several laboratories have pro-and not due to an increased association between the
vided evidence supporting an obligatory role of theAMPAR and PI3K, as there was no detectable alteration
GluR1 CT in mediating NMDAR-mediated, activity-in the ability of anti-GluR2 to coimmunoprecipitate p85
dependent AMPAR insertion (Hayashi et al., 2000; Pas-from slices treated with glycine (Figure 7C; 106.1% 
safaro et al., 2001) or hippocampal CA1 LTP (Zamanillo30.1% of control; n  8; p  0.05). Consistent with the
et al., 1999). In particular, Passafaro et al. have recentlyrequirement for physical association between AMPAR
reported that, in cultured hippocampal neurons, glycineand PI3K in the ability of GluR2 antibody to immunopre-
or NMDA stimulation facilitates the plasma membranecipitate the PI3K activity, incubation of the slice lysates
insertion of transiently expressed recombinant GluR1prior to immunoprecipitation with GST-GluR2833–853 but
but not GluR2 in a PI3K-dependent manner (Passafaronot GST-GluR2854–883 reduced PI3K activity in the GluR2
et al., 2001). Since PI3K can potentially bind to all GluRimmunocomplex of glycine-treated slices to a level even
subunits, the PI3K-dependent and GluR1-specificlower than that in control slices (Figure 7D). As shown
AMPAR insertion during LTP expression could not bein Figure 7E, a similar activation of AMPAR-associated
solely explained by the direct binding between PI3K andPI3K activity by glycine could also be demonstrated
GluR subunits. In other words, in addition to the PI3K-in cultured hippocampal neurons following the same
AMPAR interaction identified here, a GluR1 subunit-glycine stimulation protocol that produced LTP of
mEPSCs (Figure 1) and increased plasma membrane dependent process that is either up- or downstream of
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Figure 7. AMPAR-Associated PI3K Is Acti-
vated by Selective Stimulation of Synaptic
NMDARs
Hippocampal slices were treated with either
NMDA (50 M), AMPA (50 M), glycine (200
M), or glycine (200 M)  APV (50 M). Tis-
sue homogenates from drug-treated slices or
slices without any drug treatment (Control)
were then immunoprecipitated with either
anti-GluR2 or anti-p85 antibodies or control
IgG. The immunocomplexes, along with puri-
fied, active PI3K as a positive control (PI3K),
were subjected to the PI3K activity assay.
(A) NMDA treatment has little effect on PI3K
activity in the AMPAR immunocomplex (IP:
GluR2), whereas the activity of AMPAR-asso-
ciated PI3K is dramatically increased in slices
treated with glycine. Moreover, the glycine-
induced enhancement of PI3K activity is
blocked by coapplication of NMDAR antago-
nist APV (Gly  APV). In contrast, glycine
stimulation did not alter the activity of the
total cellular pool of PI3K that was immuno-
precipitated with anti-p85 antibody (IP: PI3K).
(B) Summary of the changes in AMPAR-asso-
ciated PI3K. PI3K activity was normalized by
taking the values of the autoradiographic
density of their own internal untreated con-
trols as 1 (n  3–5 experiments).
(C) Glycine treatment does not affect the
PI3K-AMPAR association. Western blots se-
quentially probed with anti-p85 and anti-
GluR2 antibodies (IB: p85 and GluR2) show
there is no obvious alteration in the ability of
anti-GluR2 antibody (IP: GluR2) to coimmu-
noprecipitate p85 in slices treated with or
without glycine (200 M). An amount of p85
was quantified by normalizing the intensity of
the p85 band to that of GluR2 and expressed as percentage of control levels in the graph on the right (n  8; p  0.05).
(D) Glycine-induced increase in AMPAR-associated PI3K activity requires direct interaction between p85 and GluRs. Hippocampal lysates
from control (Control) and glycine (Glycine)-treated slices were immunoprecipitated with anti-GluR2 antibody in the absence () or presence
() of one of the GST fusion proteins (50 g) under nondenaturing conditions, and the immunoprecipitates were then subjected to the PI3K
activity assay. GST-GluR2833–853 (GluR2833–853) but not GST-GluR2854–883 (GluR2854–883) nor GST alone inhibited the ability of anti-GluR2 antibody to
coimmunoprecipitate PI3K activity. Autoradiogram is representative of two replicates.
(E) Glycine stimulated AMPAR-associated PI3K activity in cultured hippocampal neurons. (Left) PI3K was coimmunoprecipitated with anti-
GluR2 antibody from tissue homogenates of control hippocampal cultures (Control) or cultures treated with glycine (Glycine; 200 M; 3 min),
and the immunoprecipitates were then subjected to either PI3K activity assay (top panel) or sequential Western blotting (bottom panels: p85
and GluR2). (Right) PI3K activity was quantified by normalizing the PI3K activity to the amount of immunoprecipitated p85 (PI3K activity/mass
ratio) and expressed as percentage of controls.
the PI3K activation may also be involved in mediating of synaptic NMDARs. As a result, the AMPAR-associ-
ated PI3K complex is in a strategic location to “sense”subunit-specific AMPAR insertion during LTP.
One well-characterized feature of LTP is the input the localized rises in Ca2 concentrations resulting from
the gating of NMDAR channels, and it provides a syn-or synapse specificity, i.e., synaptic plasticity is only
exhibited in activated synapses. Transient rises in intra- apse-selective detector for the production of LTP. The
second unique feature of PI3K, with regard to its candi-cellular Ca2 within the activated synaptic spine region
as a consequence of Ca2 influx through the activated dacy as a mediator of LTP input specificity, comes from
its lipid products. Unlike most diffusible cytosolic sec-NMDARs have been suspected to be one of the major
mechanisms mediating this synaptic specificity (Bliss ond messengers, once produced, PtdIns-3Ps remain
in the membrane, thereby ensuring that the activatedand Collingridge, 1993; Malenka and Nicoll, 1999). How-
ever, the signaling molecules activated directly by these signaling cascades that lead to LTP are restricted to
activated synapses.intrasynaptic rises in [Ca2]i remain unidentified. Two
unique features associated with PI3K make the AMPAR- PI3K is known to be activated by complexed Ca2
and calmodulin (Joyal et al., 1997). NMDAR activationassociated PI3K complex one of the most attractive
candidate molecules for the link between activation of causes a localized rise in Ca2 sufficient to form a Ca2-
calmodulin complex. This complex can potentially acti-synaptic NMDARs and the production of LTP. First,
through its association with AMPARs, PI3K is compart- vate the AMPAR-associated PI3K, thereby mediating
specific AMPAR insertion within these activated syn-mentalized within the postsynaptic density of gluta-
matergic synapses and hence is recruited to the vicinity apses. However, the NMDAR-dependent increase in
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Figure 8. Proposed Role of AMPAR-Associ-
ated PI3K in LTP
We tentatively speculate that there is a re-
serve pool of AMPAR-containing vesicles
within the dendritic spines or in their vicinity.
Under basal conditions, these vesicles are
constitutively inserted into synaptic plasma
membranes at a relatively slow rate to coun-
teract a slow constitutive AMPAR endocyto-
sis, thereby ensuring a constant number of
postsynaptic AMPARs (Liang and Huganir,
2001; Man et al., 2000b). Following LTP stimu-
lation protocols, Ca2 influx through the acti-
vated NMDARs results in a transient and lo-
calized rise in [Ca2]i within the activated
synapses. Once the [Ca2]i is sufficient, there
is a sequential translocation and activation of
CaM-KII (Bayer et al., 2001; Shen and Meyer,
1999) and Ras (Zhu et al., 2002) within these
synapses. Ras then activates AMPAR-asso-
ciated PI3K (Downward, 1997; Rodriguez-Viciana et al., 1996), resulting in the production and accumulation of membrane binding PtdIns-3Ps
within the activated synapses. PtdIns-3Ps, in turn, facilitate membrane fusion of AMPAR-containing vesicles with the plasma membrane
through uncharacterized mechanisms (“?,” by affecting membrane properties or recruitment of other molecules such as kinases implicated
in LTP), resulting in the insertion of the receptors at activated synapses during the expression phase of LTP. For the sake of clarity, the
endocytotic arm of AMPAR trafficking, along with a large number of molecules previously implicated in LTP expression, have been omitted.
[Ca2]i is transient and only occurs during the induction Accumulating evidence suggests that enhanced syn-
aptic insertion of AMPARs into the postsynaptic plasmaperiod of LTP, while the PI3K-dependent facilitation of
AMPAR insertion is maintained throughout the expres- membrane, via exocytosis of AMPAR-containing vesi-
cles, is an important postsynaptic mechanism in thesion period. Thus, how such a transient rise in [Ca2]i
is translated into a long-lasting signal responsible for expression of a number of forms of NMDAR-dependent
LTP (Lu et al., 2001; Malinow et al., 2000; Passafaro etsustained activation of PI3K and, hence, the facilitated
insertion of AMPARs remains to be elucidated. In view al., 2001; Shi et al., 1999). In addition, PI3K has also
been implicated in some forms of synaptic plasticity,of this, it is very interesting to note that activation of
NMDARs has been demonstrated to be able to recruit although the underlying mechanisms remain to be char-
acterized (Kelly and Lynch, 2000; Lin et al., 2001).and activate the serine/threonine kinase CaM-KII to
these synapses (Shen and Meyer, 1999). Once activated, PtdIns-3Ps are known to be important signaling mole-
cules involved in many membrane trafficking processesthe kinase is believed to be locked in the activated state
(Bayer et al., 2001; Lisman et al., 2002). This activation (Carpenter and Cantley, 1996; Cheever et al., 2001;
De Camilli et al., 1996; James and Piper, 1994; Rapoporthas been proposed as one of the important mechanisms
that maintain facilitated AMPAR insertion during LTP; et al., 1997), and our results are consistent with activa-
tion of the AMPAR-associated PI3K complex, followinghow the lasting activation of CaM-KII leads to a main-
tained increase in AMPAR insertion remains unclear. the selective activation of synaptic NMDARs. The accu-
mulation of PI3K products near AMPAR-containing vesi-As mutation of the CaM-KII phosphorylation site in the
GluR1 CT did not prevent the synaptic delivery of cles might then directly or indirectly stimulate localized
plasma membrane insertion of AMPARs only at acti-AMPARs, direct phosphorylation of GluR1 by CaM-KII
may not be a critical event leading to facilitated AMPAR vated synapses. The mechanism by which such a synap-
tic accumulation of PtdIns-3Ps facilitates AMPAR inser-insertion (Hayashi et al., 2000). Zhu et al. have recently
provided strong evidence suggesting that CaM-KII may tion into these synapse membranes during LTP remain
to be established. In this respect, it has been shown infacilitate AMPAR insertion by activating Ras (Zhu et al.,
2002). In light of this, it is significant to note that Ras is yeast that PtdIns-3Ps recruit tSNARE Vam7, via their PX
binding domains, to PtdIns-3P-enriched vacuoles andknown to activate PI3K by mechanisms including a di-
rect interaction with the catalytic subunit of the lipid thereby facilitate the docking and fusion of transport
intermediates with the vacuole (Cheever et al., 2001).kinase (Downward, 1997; Rodriguez-Viciana et al.,
1996). Thus, we can tentatively propose, as illustrated Thus, one possibility is that accumulation of PtdIns-3Ps
in the vicinity of AMPAR-containing vesicles may affectin Figure 8, that selective activation of synaptic NMDARs
may lead to a transient rise in [Ca2]i localized within the the physical properties of the postsynaptic plasma
membrane and/or the membrane of the AMPAR-con-activated synapses, which in turn recruits and activates
CaM-KII and Ras. Ras then binds and activates AMPAR- taining vesicles in these synapses and consequently
prime or facilitate the fusion process between the twoassociated PI3K, leading to lasting facilitation of AMPAR
insertion. In this model, NMDAR activation and a tran- membranes. In addition, PtdIns-3Ps are known to spe-
cifically bind other protein modules such as PH andsient increase in [Ca2]i in the activated synapses is a
critical signal involved in mediating the induction of LTP FYVE domains (Stenmark and Aasland, 1999). It is possi-
ble that accumulation of PtdIns-3Ps around the AMPAR-within these synapses, while the activation of CaM-KII/
Ras and subsequent activation of AMPAR-associated containing vesicles recruits a PtdIns-3P binding mod-
ule-containing signaling complex, such as the serine/PI3K are responsible for the maintenance and expres-
sion (AMPAR insertion) of LTP, respectively. threonine kinases PKC and Akt (Vanhaesebroeck et al.,
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GluR2 antibody and an FITC-conjugated anti-mouse secondary anti-1997), to activated synapses, thereby creating localized
body. The images were acquired using a 63 objective lens on asignaling cascades responsible for insertion of AMPARs
Zeiss confocal microscope (1024  1024 pixels).into the plasma membrane at these synapses during the
expression of LTP. Therefore, identifying the molecules
Cell-ELISA Assays
immediately downstream of the AMPAR-associated The measurement of the steady-state level of cell surface AMPARs
PI3K complex [i.e., the effector(s) of PtdIns-3Ps] should (cell surface receptor assays) were performed as described pre-
facilitate our efforts in understanding the molecular viously (Man et al., 2000b). In brief, cultured hippocampal neurons
were treated with glycine (200 M), with or without PI3K inhibitorsmechanisms underlying LTP.
LY294002 (10 M) or wortmannin (100 nM), in the perfusion solution
for 3–5 min and then allowed to recover in perfusion solution (withoutExperimental Procedures
glycine) for 15–20 min. Following 10 min fixation with 2% paraformal-
dehyde and, for some cells, permeabilization with 0.2% Triton X-100mEPSCs in Neuronal Cultures
in PBS for 10 min, neurons were labeled with a polyclonal antibodyCultured mouse hippocampal neurons were grown as previously
against the N-terminal extracellular domain of the rat GluR1 receptordescribed (Lu et al., 2001). Whole-cell recordings were made from
(Oncogene Research, 1:100) and a horseradish peroxidase (HRP)-these cultures 12–17 days after plating. Patch electrodes were
conjugated anti-rabbit secondary antibody (1:1000). Cells werecoated with Sylgard to improve signal-to-noise ratios. Recordings
washed five times with PBS to minimize nonspecific reactivity thenwere performed at room temperature (20
C–22
C). Recordings from
they were incubated with 1 ml of HRP substrate OPD (Sigma) foreach neuron lasted for at least 40–80 min. Recordings where the
2–5 min. Reactions were stopped with 0.2 ml 3 N HCl, and the opticalseries resistance varied by more than 10% were rejected. No elec-
density of the supernatant was read on a spectrophotometer at 492tronic compensation for series resistance was employed. The intra-
nm. The levels of cell surface expression of AMPARs were presentedcellular recording (patch electrode) solution contained (in mM) CsCl2,
as the ratio of colorimetric readings under nonpermeabilized condi-140; EGTA, 2.5; MgCl2, 2; HEPES, 10; TEA, 2; K2ATP, 4; plus or minus
tions to those under permeabilized conditions and were normalizedactive or heat-inactivated PI3K (1 g/ml); at pH 7.3 and osmolarity
to untreated control values.300–310 mosmol1. The extracellular recording solution (ECS) con-
For quantification of AMPAR insertion using cell-ELISA (AMPARsisted of (in mM) NaCl, 140; CaCl2, 1.3; KCl, 5.0; HEPES, 25; glucose,
insertion assay [Lu et al., 2001]), cell surface AMPARs were first33; TTX, 0.0005; strychnine, 0.001; bicuculline methiodide, 0.02; at
blocked with anti-GluR2 antibody and a non-HRP conjugated sec-pH 7.4 and osmolarity 325–335 mosmol1. Each cell was continu-
ondary antibody as described above in the immunocytochemistryously superfused (1.0 ml/min) with the extracellular solution from
section, and newly inserted AMPARs were then labeled with thea single barrel of a computer-controlled multi-barreled perfusion
same primary antibody and an HRP-conjugated secondary antibodysystem. Solutions supplemented with glycine or glycine and NMDA
under nonpermeabilized conditions followed by detection with HRP-were applied from an alternate barrel. mEPSCs were recorded using
OPD reactions. The entire cellular pool of AMPARs was assayedan Axopatch 1-B amplifier (Axon Instruments Inc., Union City, CA),
using the same method under permeabilized conditions. The leveland records were filtered at 2 kHz, stored on tape, and subsequently
of insertion was then determined by taking the ratio of readingsacquired offline with an event detection program (SCAN, Strathclyde
under nonpermeant over permeant conditions. For quantification ofsoftware, courtesy of Dr. J. Dempster). The trigger level for detection
AMPAR endocytosis using cell-ELISA (AMPAR endocytosis assayof events was set approximately three times higher than the baseline
[Lu et al., 2001; Man et al., 2000b]), live cells were incubated withnoise. Inspection of the raw data was used to eliminate any false
the anti-GluR2 antibody recognizing the N-terminal extracellular do-events.
main at 4
C to prelabel cell surface AMPARs. Following treatments
at 37
C for various times as indicated in the text and the legendImmunocytochemisty
of Figure 4D, cells were respectively labeled with HRP-conjugatedImmunocytochemistry was performed essentially as previously re-
secondary antibody under nonpermeant (to detect prelabeled re-ported (Man et al., 2000b). For colocalization, cultured hippocampal
ceptors that remained on the cell surface) and permeant conditionsneurons were washed briefly with D-PBS and then fixed for 10 min
(to detect prelabeled receptors that had been endocytosed into thewith 4% paraformaldehyde in D-PBS without cell permeabilization.
cell interior), followed by detection with HRP-OPD as describedNeurons were then blocked in 10% normal goat serum in D-PBS
above. Levels of AMPAR endocytosis were then determined by theprior to overnight incubation with 1:1000 mouse monoclonal anti-
ratio of colorimetric readings under nonpermeabilized and perme-body recognizing the N-terminal extracellular domain of GluR2 (anti-
abilized conditions and were normalized to untreated control values.GluR2, Chemicon International, Inc., Temecula, CA) and with Cy5
conjugated anti-mouse secondary antibodies. Neurons were then
GST Fusion Proteins and Affinity Precipitationspermeabilized with 0.1% Triton in D-PBS for 5 min and incubated
pGEX2T-GluR1CT and pGEX2T-GluR2CT plasmids were gifts fromfor 1 hr at room temperature with a rabbit polyclonal antibody
Morgan Sheng (Harvard Medical School). Corresponding GST fusionagainst the p85 subunit of PI3K at a dilution of 1:1000 (Upstate
proteins were produced and purified from bacterial lysates usingBiotechnology, Lake Placid, NY) and FITC conjugated anti-rabbit
procedures suggested by the manufacturer (Amersham Biosci-antibodies. Following extensive washes, the neurons were incu-
ences, Baie d’Urfe´, PQ). Active recombinant PI3K (p85/p110) com-bated again with a goat polyclonal antibody against synaptophysin
plex was purified on PY-beads from Sf9 cells infected with p85 and(1:1000, Santa Cruz Biotechnology Inc., Santa Cruz, CA) and a Cy3
p110 recombinant baculovirus. [35S]methionine-labeled p85 subunitconjugated anti-goat antibody for 1 hr at room temperature. Neurons
([35S]p85) was generated using Promega’s TNT quick coupled Tran-were washed extensively and then mounted prior to imaging on a
scription/Translation Kit according to the manufacturer’s instruc-Zeiss LSM510 confocal microscope. Methods for confocal fluores-
tions. GST fusion proteins (30–50 mg) conjugated to glutathionecent microscopic visualization of newly inserted AMPARs have been
sepharose beads were incubated overnight with recombinant PI3Kpreviously described (Lu et al., 2001). In brief, live hippocampal cells
complex or [35S]p85 in RIPA buffer. The pellets were then washedwere first incubated with the monoclonal anti-GluR2 antibody (1:500;
three times with the same buffer. Affinity-precipitated PI3K com-Chemicon International, Inc.) for 45 min and a cold (nonconjugated)
plexes were detected by the PI3K activity assay described below.secondary antibody (5 g/mL; Sigma, St. Louis, MO) for another 45
For detecting [35S]p85 precipitated by GST fusion proteins, the pel-min at 4
C to block the preexisting cell surface AMPARs. Following
lets were eluted using 2 sample buffer and then subjected to SDS-treatments at 37
C for various times as detailed in the text and the
PAGE and autoradiography.legend of Figure 4, the cells were fixed and stained with the same
anti-GluR2 primary antibody and Cy3-conjugated anti-mouse sec-
ondary antibody to detect the newly inserted AMPARs on the plasma Immunoprecipitation, Western Blotting, and PI3K Assays
Hippocampal slices (300 m thickness) were prepared from adultmembrane surface. The cells were then permeabilized with 0.1%
Triton X-100 in PBS for 5 min, rinsed thoroughly with PBS and then Sprague-Dawley rats (150–200 g) and maintained in standard artifi-
cial cerebrospinal fluid aerated with 95% O2/5% CO2 at room tem-stained for intracellularly localized AMPARs using the same anti-
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perature as described elsewhere (Man et al., 2000b). Following a 1 References
hr recovery period, slices were subjected to various drug treatments
for 5–10 min. Control slices and slices treated with either NMDA (50 Bayer, K.U., De Koninck, P., Leonard, A.S., Hell, J.W., and Schulman,
H. (2001). Interaction with the NMDA receptor locks CaMKII in anM), AMPA (50 M), glycine (200 M), or glycine  APV (50 M) in
the presence of the glycine receptor antagonist strychnine (10 M) active conformation. Nature 411, 801–805.
were then homogenized in RIPA buffer (50 mM Tris-HCl, 150 mM Bear, M.F., and Malenka, R.C. (1994). Synaptic plasticity: LTP and
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